Rohit Kulkarni, Roth MKM managing director, joins 'Squawk on the Street' to discuss how the ban of TikTok impacts the social ...

Roth MKM analyst Rohit Kulkarni reiterated a Buy rating on Alphabet Class A (GOOGL – Research Report) today and set a price target of $225.00.

Roth MKM analyst Rohit Kulkarni reiterated a Buy rating on Amazon (AMZN – Research Report) today and set a price target of $260.00. The ...

Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with ...

Fintel reports that on January 10, 2025, Roth MKM initiated coverage of Cingulate (NasdaqCM:CING) with a Buy recommendation.

American Superconductor (NASDAQ:AMSC – Get Free Report) is expected to be announcing its earnings results before the market ...

On Friday, LivePerson Inc (LPSN) stock saw a decline, ending the day at $1.33 which represents a decrease of $-0.05 or -3.62% from the prior close of $1.38. The stock opened at $1.37 and touched a low ...

Shares of D-Wave Quantum Inc. (NYSE:QBTS – Get Free Report) have been assigned a consensus recommendation of “Buy” from the ...

Stock Trading Recap. On Friday, Reviva Pharmaceuticals Holdings Inc (RVPH) stock saw a decline, ending the day at $1.77 which represents ...

Fintel reports that on January 10, 2025, Roth MKM initiated coverage of Verona Pharma plc - Depositary Receipt () (NasdaqGM:VRNA) with a Buy recommendation. As of December 23, 2024, the average ...

Friday - Shares of Verona Pharma (NASDAQ:VRNA) received a positive outlook from Roth/MKM as the firm initiated coverage with a Buy rating and a 12-month price target of $68. The bullish stance is ...